SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

Share Price is delayed by 15 minutes
Get Live Data
182.50    5.50 (3.05%)
Bid:
180.00
Ask:
185.00
Spread: 5.00 (2.778%)
Market Cap: £90.07m
SPSY Live PriceLast checked at - London Stock Exchange

Intraday Spectra (unres) Share Chart

Trading Update

30 Jan 2014 07:00

RNS Number : 8428Y
Spectra Systems Corporation
30 January 2014
Β 

ο»Ώ

January 30, 2014

Β 

Spectra Systems Corporation

("Spectra Systems" or the "Company")

G8 Central Bank New Generation Materials and Sensor Program Cancellation and Trading Update

The Board is disappointed that a G8 central bank customer which has been funding the materials and sensor development for a new generation technology has notified the Company that it has decided to cancel this program. To date the company has demonstrated a functional sensor prototype and has had numerous successful trials of the material incorporated in the embodiment of use by the central bank.

Spectra Systems continues to own all of the developed intellectual property, specific covert materials and sensor designs developed under this program. In addition, it expects that the specific materials and data will be unclassified and will be available to the Company to use commercially with another central bank customer.

Importantly the Board is pleased to announce that phosphour sales have in the last three months recovered to levels not experienced since 2011.

In addition it expects Spectra System's performance for the year ended 31 December 2013 to be in line with market expectations. The Board expects to release the Company's preliminary results for the year ended 31 December 2013 in April 2014.

Β 

Nabil Lawandy, Spectra System's CEO, stated:

"The manner in which this program came to an abrupt halt is gravely disappointing and a loss to the central bank which has spent over $1MM in development of materials and sensor design. Trials were performed over the last year with success and in the last technical discussions, enthusiasm was evident for the project and the success in the refinements made over the last year. In fact, a final large scale test before incorporation into banknotes had been scheduled for 24 February of this year.

We are now free to take this fully completed technology to other central banks as a ready package paid for by the central bank rather than shareholders. We will pursue this aggressively.

In the meantime, this will have minimal impact on market expectations as only negligible revenues relating thereto had been anticipated in such expectations. In addition, this decision by the G8 central bank is not expected to have any impact on current generation business with the central bank to whom we will continue to deliver upgraded sensors throughout the year.

Whilst this news is disappointing, the Board is delighted that phosphour sales have recovered to previous levels."

Β 

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAAFNADPLEAF
Date   Source Headline
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company
26th Jun 20177:00 amRNSIssuance of Patents
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSIssuance of Patents
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company
5th May 20167:00 amRNSFirst TruBrand customer
18th Apr 20169:41 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSPreliminary Results
16th Feb 20167:00 amRNSExpected grant of share options
8th Feb 20167:00 amRNSTrading update and expected grant of share options
29th Jan 20167:00 amRNS$3m Acquisition of Key Specialty Phosphour Assets
27th Jan 20164:01 pmRNSHolding(s) in Company
17th Dec 20154:34 pmRNSRemoval of Restrictions from Common Stock
30th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 20157:00 amRNSAGM Postponement
4th Nov 20154:28 pmRNSHolding(s) in Company
4th Nov 20151:57 pmRNSRemoval of Restrictions from Common Stock
16th Oct 20159:53 amRNSRemoval of Restrictions from Common Stock
2nd Oct 20153:17 pmRNSNotice of AGM
10th Sep 20152:30 pmRNSHolding(s) in Company
1st Sep 20154:41 pmRNSSettlement of Common Shares
1st Sep 20157:03 amRNSInterim results for 6 months ended 30 June 2015
14th Aug 20152:42 pmRNSRemoval of Restrictions from Common Stock
14th Aug 20157:00 amRNSModified Covert Materials Supply Contract
3rd Jul 20157:00 amRNSHolding(s) in Company
2nd Jul 20157:00 amRNSContract Win
19th Jun 201511:17 amRNSPosting of Annual Report and Accounts
16th Jun 20154:06 pmRNSRemoval of Restrictions from Common Stock
19th May 20158:46 amRNSRemoval of Restrictions from Common Stock
18th May 20153:50 pmRNSHolding(s) in Company
22nd Apr 20157:31 amRNSPreliminary Results
2nd Apr 20153:05 pmRNSRemoval of Restrictions from Common Stock
19th Mar 20152:23 pmRNSRemoval of Restrictions from Common Stock
5th Mar 20158:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.